Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Reynolds

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Medical Research and Opinion|June 14, 2008
Topical bovine thrombin and adverse events: a review of the literatureJohn Clark, Sheila Crean, Matthew W Reynolds
Current Medical Research and Opinion|April 24, 2012
Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care settingManjiri Pawaskar, Qian Li, Matthew W Reynolds
Clinical Therapeutics|May 19, 2009
A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteinsFrederick A Ofosu, Sheila Crean, Matthew W Reynolds
JPEN. Journal of Parenteral and Enteral Nutrition|July 14, 2011
Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims databaseCatherine J Mercaldi, Matthew W Reynolds, Robin S Turpin
Expert Review of Molecular Diagnostics|September 13, 2008
Exogenous bovine thrombin as a biomarker of exposure and outcomeSheila M Crean, Shannon L Michels, Matthew W Reynolds
Patient Safety in Surgery|March 20, 2008
Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literatureMatthew W Reynolds, John Clark, Sheila Crean, et al.
Current Medical Research and Opinion|January 15, 2010
Persistence and adherence to disease modifying drugs among patients with multiple sclerosisMatthew W Reynolds, Reejis Stephen, Chris Seaman, et al.
Journal of Medical Economics|January 19, 2010
Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugsMatthew W Reynolds, Reejis Stephen, Chris Seaman, et al.
Journal of Diabetes Science and Technology|October 27, 2011
Trend analyses of insulin delivery systems in the United StatesLauren J Lee, Qian Li, Matthew W Reynolds, et al.
The Journal of Surgical Research|July 11, 2009
Bovine thrombin safety reporting: an example of study design and publication biasSheila Crean, Shannon L Michels, Kevin Moschella, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Medical Research and Opinion|June 14, 2008
Topical bovine thrombin and adverse events: a review of the literatureJohn Clark, Sheila Crean, Matthew W Reynolds
Current Medical Research and Opinion|April 24, 2012
Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care settingManjiri Pawaskar, Qian Li, Matthew W Reynolds
Clinical Therapeutics|May 19, 2009
A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteinsFrederick A Ofosu, Sheila Crean, Matthew W Reynolds
JPEN. Journal of Parenteral and Enteral Nutrition|July 14, 2011
Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims databaseCatherine J Mercaldi, Matthew W Reynolds, Robin S Turpin
Expert Review of Molecular Diagnostics|September 13, 2008
Exogenous bovine thrombin as a biomarker of exposure and outcomeSheila M Crean, Shannon L Michels, Matthew W Reynolds
Patient Safety in Surgery|March 20, 2008
Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literatureMatthew W Reynolds, John Clark, Sheila Crean, et al.
Current Medical Research and Opinion|January 15, 2010
Persistence and adherence to disease modifying drugs among patients with multiple sclerosisMatthew W Reynolds, Reejis Stephen, Chris Seaman, et al.
Journal of Medical Economics|January 19, 2010
Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugsMatthew W Reynolds, Reejis Stephen, Chris Seaman, et al.
Journal of Diabetes Science and Technology|October 27, 2011
Trend analyses of insulin delivery systems in the United StatesLauren J Lee, Qian Li, Matthew W Reynolds, et al.
The Journal of Surgical Research|July 11, 2009
Bovine thrombin safety reporting: an example of study design and publication biasSheila Crean, Shannon L Michels, Kevin Moschella, et al.
Pageof 5